Medicare Enrolled
Dr. Sakshi Kapur, M.D.
Internal Medicine · Berkeley Heights, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kapur from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kapur?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kapur
Dr. Sakshi Kapur is an internal medicine specialist in Berkeley Heights, NJ, with 13 years of NPI registration. Based on federal Medicare data, Dr. Kapur performed 37,577 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kapur received a total of $9,889 from 46 pharmaceutical and/or device companies across 422 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kapur is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 0% volume in NJ
$9,889 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗37,577
Medicare services
Top 0% in NJ for internal medicine
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
21,000 | $1 | $2 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
5,540 | $36 | $67 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
4,920 | $6 | $15 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,852 | $6 | $12 |
| Denosumab injection (Prolia/Xgeva) | 1,680 | $19 | $32 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
505 | $12 | $63 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
378 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
250 | $107 | $202 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
217 | $18 | $70 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
189 | $55 | $225 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
168 | $146 | $271 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
109 | $1 | $3 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
99 | $14 | $59 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
95 | $25 | $100 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
78 | $115 | $478 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
73 | $6 | $27 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
72 | $22 | $120 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
71 | $1 | $3 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
63 | $74 | $70 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
47 | $20 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
35 | $8 | $9 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $134 | $304 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $72 | $136 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
28 | $100 | $192 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
19 | $11 | $45 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
15 | $29 | $145 |
| New patient office visit, complex (60-74 min) | 13 | $188 | $385 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
72.2% high complexity
25.8% medium
2.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,889
Total received (2018-2024)
Avg $1,413/year across 7 years
Top 7% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
422
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,421
2023
$3,912
2022
$1,785
2021
$1,271
2020
$145
2019
$164
2018
$192
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$341
E.R. Squibb & Sons, L.L.C.
$301
Celgene Corporation
$189
Bayer Healthcare Pharmaceuticals Inc.
$176
PFIZER INC.
$161
Rigel Pharmaceuticals, Inc.
$151
Merck Sharp & Dohme LLC
$142
GlaxoSmithKline, LLC.
$119
Genentech USA, Inc.
$108
Daiichi Sankyo Inc.
$76
JAZZ PHARMACEUTICALS INC.
$71
Gilead Sciences, Inc.
$50
ABBVIE INC.
$49
Astellas Pharma US Inc
$48
ARRAY BIOPHARMA INC
$47
Janssen Pharmaceuticals, Inc
$44
Janssen Biotech, Inc.
$35
Lilly USA, LLC
$32
Incyte Corporation
$32
Ipsen Biopharmaceuticals, Inc
$32
PharmaEssentia USA Corporation
$25
ADC Therapeutics America, Inc.
$24
Eisai Inc.
$23
SERVIER PHARMACEUTICALS LLC
$22
Exelixis Inc.
$21
Coherus Biosciences Inc.
$18
Mirati Therapeutics, Inc.
$17
Myriad Genetic Laboratories, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Regeneron Healthcare Solutions, Inc.
$16
AstraZeneca Pharmaceuticals LP
$16
Top 3 companies account for 34.3% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer Healthcare Pharmaceuticals Inc.
$1,563
Novartis Pharmaceuticals Corporation
$912
E.R. Squibb & Sons, L.L.C.
$714
Lilly USA, LLC
$489
PFIZER INC.
$485
Rigel Pharmaceuticals, Inc.
$462
GENZYME CORPORATION
$388
Merck Sharp & Dohme LLC
$382
AstraZeneca Pharmaceuticals LP
$379
Celgene Corporation
$294
Gilead Sciences, Inc.
$286
Janssen Biotech, Inc.
$284
Genentech USA, Inc.
$278
Merck Sharp & Dohme Corporation
$255
Astellas Pharma US Inc
$242
Takeda Pharmaceuticals U.S.A., Inc.
$231
Epizyme, Inc.,
$199
Incyte Corporation
$192
Myriad Genetic Laboratories, Inc.
$181
Bayer HealthCare Pharmaceuticals Inc.
$166
JAZZ PHARMACEUTICALS INC.
$165
GlaxoSmithKline, LLC.
$160
Seagen Inc.
$159
ABBVIE INC.
$109
Daiichi Sankyo Inc.
$100
ARRAY BIOPHARMA INC
$96
Janssen Pharmaceuticals, Inc
$87
Mirati Therapeutics, Inc.
$59
Pharmacyclics LLC, An AbbVie Company
$53
Ipsen Biopharmaceuticals, Inc
$48
AbbVie Inc.
$45
BeiGene USA, Inc.
$42
Eisai Inc.
$42
Otsuka America Pharmaceutical, Inc.
$38
Coherus Biosciences Inc.
$35
Sobi, Inc
$34
Amgen Inc.
$33
Pharmacyclics LLC, an AbbVie Company
$27
Kite Pharma, Inc.
$26
PharmaEssentia USA Corporation
$25
ADC Therapeutics America, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$22
Alexion Pharmaceuticals, Inc.
$22
Exelixis Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Regeneron Healthcare Solutions, Inc.
$16
Top 3 companies account for 32.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AUGTYRO · Alecensa · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Fabhalta · GAZYVA · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MYRISK · NINLARO · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · Onivyde · PADCEV · PIQRAY · PRECISETUMOR · PROMACTA · Padcev · Phesgo · Polivy · Pomalyst · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · VELCADE · VENCLEXTA · VERZENIO · XALKORI · XARELTO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
5,146
County median income
$100,117
Nearest hospital to ZIP centroid (approximate)
MOUNTAINVIEW BEHAVIORAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kapur is a mixed practice specialist, with above-average Medicare volume (top 0% in NJ).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kapur experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Kapur performed 21,000 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kapur receive payments from pharmaceutical companies?
Yes. Dr. Kapur received a total of $9,889 from 46 companies across 422 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kapur's costs compare to other internal medicine physicians in Berkeley Heights?
Dr. Kapur's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kapur) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Berkeley Heights
Browse internal medicine physicians in Berkeley Heights ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology